HOOKIPA Pharma (NASDAQ:HOOK) Shares Up 3.8% – Here’s What Happened

HOOKIPA Pharma Inc. (NASDAQ:HOOK)’s stock price shot up 3.8% during mid-day trading on Monday . The company traded as high as $1.09 and last traded at $1.09. 6,454 shares were traded during mid-day trading, a decline of 32% from the average session volume of 9,422 shares. The stock had previously closed at $1.05.

HOOKIPA Pharma Price Performance

The stock has a market capitalization of $13.29 million, a price-to-earnings ratio of -0.19 and a beta of 0.87. The firm’s fifty day moving average is $1.03 and its 200-day moving average is $0.94.

About HOOKIPA Pharma

HOOKIPA Pharma Inc is a clinical-stage biotechnology company focused on the development of virus-based immunotherapies and vaccines. The company operates two complementary platform technologies—an engineered Modified Vaccinia Ankara (MVA) vector and an arenavirus vector system—designed to stimulate both humoral and cellular immune responses. By combining these platforms, HOOKIPA aims to address infectious diseases and drive novel immuno-oncology treatments.

In the infectious disease arena, HOOKIPA’s pipeline includes prophylactic vaccine candidates targeting pathogens such as cytomegalovirus (CMV) in transplant settings and other viral threats.